West Therapeutic Development

West Therapeutic Development is a specialty pharmaceutical company headquartered in Northbrook, Illinois, specializing in the development and commercialization of complex generic and specialty drug products. The company focuses primarily on respiratory medicine, utilizing advanced formulation and device technologies to create generic versions of blockbuster inhaled therapies. West Therapeutic Development is recognized for its successful development of generic Advair Diskus (fluticasone propionate and salmeterol), which was brought to market through a strategic partnership with Hikma Pharmaceuticals. The company's portfolio includes a range of inhaled corticosteroids and long-acting beta-agonists designed to treat asthma and chronic obstructive pulmonary disease (COPD). By focusing on high-barrier-to-entry products, West Therapeutic Development aims to improve patient access to essential medications while maintaining rigorous quality standards.